156 related articles for article (PubMed ID: 15108065)
21. Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus.
Kanazawa I; Yamaguchi T; Yamauchi M; Yamamoto M; Kurioka S; Yano S; Sugimoto T
Osteoporos Int; 2011 Jan; 22(1):187-94. PubMed ID: 20165834
[TBL] [Abstract][Full Text] [Related]
22. Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women.
Szulc P; Arlot M; Chapuy MC; Duboeuf F; Meunier PJ; Delmas PD
J Bone Miner Res; 1994 Oct; 9(10):1591-5. PubMed ID: 7817805
[TBL] [Abstract][Full Text] [Related]
23. Plasma phylloquinone, menaquinone-4 and menaquinone-7 levels and coronary artery calcification.
Torii S; Ikari Y; Tanabe K; Kakuta T; Hatori M; Shioi A; Okano T
J Nutr Sci; 2016; 5():e48. PubMed ID: 28620475
[TBL] [Abstract][Full Text] [Related]
24. Ethnic differences in osteocalcin gamma-carboxylation, plasma phylloquinone (vitamin K1) and apolipoprotein E genotype.
Beavan SR; Prentice A; Stirling DM; Dibba B; Yan L; Harrington DJ; Shearer MJ
Eur J Clin Nutr; 2005 Jan; 59(1):72-81. PubMed ID: 15340366
[TBL] [Abstract][Full Text] [Related]
25. Effect of GGCX gene polymorphism on the responses of serum undercarboxylated osteocalcin and bone turnover markers after treatment with vitamin K2 (menatetrenone) among postmenopausal Thai women.
Songpatanasilp T; Chailurkit LO; Chantprasertyothin S; Ongphiphadhanakul B; Taechakraichana N
J Bone Miner Metab; 2011 Sep; 29(5):606-14. PubMed ID: 21344298
[TBL] [Abstract][Full Text] [Related]
26. The effects of vitamin K-rich green leafy vegetables on bone metabolism: A 4-week randomised controlled trial in middle-aged and older individuals.
Sim M; Lewis JR; Prince RL; Levinger I; Brennan-Speranza TC; Palmer C; Bondonno CP; Bondonno NP; Devine A; Ward NC; Byrnes E; Schultz CJ; Woodman R; Croft K; Hodgson JM; Blekkenhorst LC
Bone Rep; 2020 Jun; 12():100274. PubMed ID: 32455149
[TBL] [Abstract][Full Text] [Related]
27. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women.
Knapen MH; Drummen NE; Smit E; Vermeer C; Theuwissen E
Osteoporos Int; 2013 Sep; 24(9):2499-507. PubMed ID: 23525894
[TBL] [Abstract][Full Text] [Related]
28. Vitamin K in combination with other biochemical markers to diagnose osteoporosis.
Heiss C; Hoesel LM; Wehr U; Keller T; Horas U; Meyer C; Rambeck W; Schnettler R
Biomarkers; 2004; 9(6):479-88. PubMed ID: 15849068
[TBL] [Abstract][Full Text] [Related]
29. Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.
Chiba Y; Onouchi T; Ikeda T; Adachi J; Tamura Y; Horiuchi T
Gerontology; 2009; 55(3):275-80. PubMed ID: 19158438
[TBL] [Abstract][Full Text] [Related]
30. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis.
Shiraki M; Shiraki Y; Aoki C; Miura M
J Bone Miner Res; 2000 Mar; 15(3):515-21. PubMed ID: 10750566
[TBL] [Abstract][Full Text] [Related]
31. Response of serum carboxylated and undercarboxylated osteocalcin to risedronate monotherapy and combined therapy with vitamin K(2) in corticosteroid-treated patients: a pilot study.
Hozuki T; Imai T; Tsuda E; Matsumura A; Yamamoto D; Toyoshima T; Suzuki S; Yamauchi R; Hayashi T; Hisahara S; Shimohama S
Intern Med; 2010; 49(5):371-6. PubMed ID: 20190467
[TBL] [Abstract][Full Text] [Related]
32. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women.
Szulc P; Chapuy MC; Meunier PJ; Delmas PD
J Clin Invest; 1993 Apr; 91(4):1769-74. PubMed ID: 8473517
[TBL] [Abstract][Full Text] [Related]
33. Serum concentration of undercarboxylated osteocalcin and the risk of osteoporosis in thai elderly women.
Soontrapa S; Soontrapa S; Bunyaratavej N
J Med Assoc Thai; 2005 Oct; 88 Suppl 5():S29-32. PubMed ID: 16869104
[TBL] [Abstract][Full Text] [Related]
34. Correlation of undercarboxylated osteocalcin (ucOC) concentration and bone density with age in healthy Korean women.
Kim SM; Kim KM; Kim BT; Joo NS; Kim KN; Lee DJ
J Korean Med Sci; 2010 Aug; 25(8):1171-5. PubMed ID: 20676328
[TBL] [Abstract][Full Text] [Related]
35. Level of undercarboxylated osteocalcin in reproductive Thai females.
Bunyaratavej N; Soontrapa S; Rojanasthin S; Kitimanon N; Lektrakul S
J Med Assoc Thai; 2005 Oct; 88 Suppl 5():S37-9. PubMed ID: 16869105
[TBL] [Abstract][Full Text] [Related]
36. Age-related changes in serum undercarboxylated osteocalcin and its relationships with bone density, bone quality, and hip fracture.
Liu G; Peacock M
Calcif Tissue Int; 1998 Apr; 62(4):286-9. PubMed ID: 9504950
[TBL] [Abstract][Full Text] [Related]
37. Effects of vitamin K in postmenopausal women: mini review.
Guralp O; Erel CT
Maturitas; 2014 Mar; 77(3):294-9. PubMed ID: 24342502
[TBL] [Abstract][Full Text] [Related]
38. Vitamin K supplement along with vitamin D and calcium reduced serum concentration of undercarboxylated osteocalcin while increasing bone mineral density in Korean postmenopausal women over sixty-years-old.
Je SH; Joo NS; Choi BH; Kim KM; Kim BT; Park SB; Cho DY; Kim KN; Lee DJ
J Korean Med Sci; 2011 Aug; 26(8):1093-8. PubMed ID: 21860562
[TBL] [Abstract][Full Text] [Related]
39. Undercarboxylated osteocalcin is positively associated with free testosterone in male patients with type 2 diabetes mellitus.
Kanazawa I; Tanaka K; Ogawa N; Yamauchi M; Yamaguchi T; Sugimoto T
Osteoporos Int; 2013 Mar; 24(3):1115-9. PubMed ID: 22669468
[TBL] [Abstract][Full Text] [Related]
40. Effects of long-term vitamin K(1) (phylloquinone) or vitamin K(2) (menaquinone-4) supplementation on body composition and serum parameters in rats.
Sogabe N; Maruyama R; Baba O; Hosoi T; Goseki-Sone M
Bone; 2011 May; 48(5):1036-42. PubMed ID: 21295170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
